[Distribution and risk factors of hydatidosis in an administrative region of Chile between 2010 and 2016].

Background: In Chile, hydatidosis is endemic throughout the country and hyperendemic in some regions. It continues to be a public health problem that has been neglected and little addressed at the national level. In the Region of Libertador Bernardo O'Higgins, reported cases and hospital discharges still show high values, this area being representative of medium risk.

A multicenter prospective trial evaluating fetal bovine dermal graft (Xenform® Matrix) for pelvic reconstructive surgery.

Background: A prospective multicenter clinical study was performed to evaluate the safety and efficacy of a bovine dermal graft (Xenform® Matrix, Boston Scientific, Natick, MA, USA) during vaginal reconstructive surgery.

Methods: Forty-five women with ICS stage 2 or higher pelvic organ prolapse (POP) were enrolled at 4 centers. POP-Q, pelvic floor function (PFDI-20), sexual function (PISQ-12), and patient satisfaction tools were used to assess subjects at baseline, and at 2 and 6 weeks, and 3, 6 and 12 months post surgery.

An inexpensive polypropylene patch sling for treatment of intrinsic sphincteric deficiency.

Study Objective: To evaluate an inexpensive polypropylene sling in patients with intrinsic sphincteric deficiency (ISD).

Design: Case series (Canadian Task Force classification II-2).

Setting: Cleveland Clinic Florida teaching hospital.

Anterior repair with or without collagen matrix reinforcement: a randomized controlled trial.

Objective: To compare outcomes of anterior colporrhaphy alone to that reinforced with bovine pericardium graft.

Methods: Women with anterior vaginal wall prolapse were enrolled in a randomized fashion in this grafted compared with nongrafted repair study. Outcome measures included pelvic organ prolapse quantification data, quality-of-life assessment, healing abnormalities, and complications.

Safety and effectiveness of Colpexin Sphere in the treatment of pelvic organ prolapse.

Our objective was to determine the safety and effectiveness of Colpexin Sphere in women with advanced genital prolapse. A total of 39 subjects were enrolled in our prospective multicenter clinical trial, and 27 completed the full 16-week assessment. At baseline, subjects were fitted with a sphere, instructed on insertion and removal, and educated on a regimen of pelvic floor muscle exercises performed with the device in place.

Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.

Background: Oophorectomy reduces serum testosterone levels. We studied the efficacy and safety of transdermal testosterone in treating hypoactive sexual desire disorder in surgically menopausal women.

Methods: A 24-week, randomized, double-blind, placebo-controlled, parallel-group, multicenter trial was conducted in women (aged 24-70 years) who developed distressful low sexual desire after bilateral salpingo-oophorectomy and hysterectomy and who were receiving oral estrogen therapy.

Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial.

Objective: To assess the efficacy and safety of a 300 mug/d testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women on concomitant estrogen therapy.

Methods: Five hundred thirty-three women with hypoactive sexual desire disorder who had undergone previous hysterectomy and bilateral oophorectomy were enrolled in a 24-week, multicenter, double-blind, placebo-controlled trial. Patients were randomly assigned to receive placebo or the testosterone patch twice weekly.